Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/6/2025

Frontalis Neuromodulator Treatment Safety Considerations

Adverse Events and Clinical Monitoring

  • The primary risk of botulinum toxin A treatment involves diffusion of toxin from target muscles to adjacent structures, which has been designated as an FDA "boxed warning" by the American Academy of Otolaryngology-Head and Neck Surgery 1
  • Adjusting dose, distribution, and timing of injections can minimize adverse event frequency, according to the American Academy of Otolaryngology-Head and Neck Surgery 1
  • Effects of botulinum toxin A are temporary and reversible, typically lasting 3-6 months, as reported by the American Academy of Otolaryngology-Head and Neck Surgery 1

Timing of Massage After Botulinum Toxin Injections

Rationale Based on Toxin Pharmacodynamics

  • Light touch massage poses less risk than deep tissue manipulation, and myofascial release techniques that apply sustained pressure directly over injection sites carry the highest risk of toxin displacement, according to guidelines from the American Urological Association 2

Common Pitfalls and How to Avoid Them

  • Aggressive myofascial release techniques are relatively contraindicated in the first 2 weeks after botulinum toxin injections, as they may increase the risk of toxin migration, as noted by the American Urological Association 2

REFERENCES

1

clinical practice guideline: hoarseness (dysphonia). [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2009